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Summary Epileptic seizures are a frequent manifestation of Hashimoto’s encepha-
lopathy. However, status epilepticus associated with Hashimoto’s encephalopathy are
not well characterized in medical literature. We described here a 16-year-old girl who
presented with complex partial status epilepticus associated with elevated anti-
thyroid antibodies. Ictal EEG showed lateralized high amplitude rhythmic delta waves
over the right hemisphere and ictal single-photon emission computed tomography
revealed regional hyperperfusion of the right parietal and temporal lobes. The patient
was unresponsive to antiepileptic drug therapy but responded to intravenous steroid
treatment. Screening of serum anti-thyroid antibodies for unexplained encephalo-
pathy with epileptic seizures is suggested, as early recognition and prompt steroid
treatment may lead to a favorable prognosis.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Hashimoto’s encephalopathy is a rare, chronic
relapsing and remitting encephalopathy associated
with auto-antibodies against thyroid components.1
Clinical presentations of Hashimoto’s encephalo-* Corresponding author at: Department of Neurology, Chang
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doi:10.1016/j.seizure.2007.05.018pathy are usually non-specific, and common
neurologic manifestations include cognitive
impairment, behavior changes, stroke-like epi-
sodes, seizures, psychosis, tremor, myoclonus, stu-
por, and even myelopathy.1,2 Epileptic seizures,
both generalized and partial, are common mani-
festations that have been reported in 66% of
patients.1,3 However, status epilepticus occurring
with Hashimoto’s encephalopathy is infrequently
reported in the literature. We report here a case of
Hashimoto’s encephalopathy presenting as com-
plex partial status epilepticus and review other
reported cases in medical literatures.. Published by Elsevier Ltd. All rights reserved.
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Figure 1 Ictal EEG showed continuous, rhythmic, later-
alized delta waves over the right hemisphere.Case report
A 16-year-old girl was admitted to the Neurology
ward due to mental disturbances and prolonged
confusional states. One month before admission,
she developed subacute onset of impaired atten-
tion, bizarre behavior, self-talking, insomnia, and
mood disturbances. After admission, she had episo-
dic disorientation about 7—8 times/day, with con-
fusion and acute psychotic states. The duration of
attacks was from 30 to 40 min. Meaningless vocali-
zation, laughing, chewing, and lips smacking were
also noted during the attacks. Between episodes,
the deteriorated consciousness occasionally did not
return to the baseline. After two generalized motor
convulsions, she received treatment immediately
with intravenous lorazepam and subsequent intra-
venous phenytoin therapy (began with a loading
dose of 800 mg and maintained at 300 mg/day).
However, consciousness did not improve and episo-
dic mental changes persisted, despite serum phe-
nytoin levels were within therapeutic range. She
gradually developed intermittent, semi-rhythmic
clonic movement of the left arm, accompanied by
alternations of consciousness.
The patient’s gestational and neonatal history was
unremarkable, with normal developmental mile-
stones. There was no history of major systemic or
infectious diseases. Family history of epilepsy or
febrile convulsion was also negative. Physical exam-
ination was unremarkable. Laboratory studies,
including complete blood count, alanine transami-
nase/aspartate transaminase, blood urea nitrogen/
creatinine, and serum electrolytes were all within
normal limits. The cerebrospinal fluid was likewise
unremarkable, aswell as tests for drug screens, bloodFigure 2 (A) Ictal SPECTrevealed regional hyper-perfusion o
showed hyperintensity on fluid-attenuated inversion recoverylead and copper level, porphyria screens, syphilis,
anti-nuclear antibody, viral infections (herpes sim-
plex virus, human immunodeficiency virus, hepatitis
B, hepatitis C, and cytomegalovirus and Epstein-Barr
virus), tumor makers, and serum electrophoresis.
Ictal electroencephalogram (EEG) revealed con-
tinuous high amplitude rhythmic lateralized delta
waves over the right hemisphere (Fig. 1). Intermit-
tent photic stimulation during EEG studies did not
evoke abnormal photoparoxysmal response. Ictal
brain 99mTc single-photon emission computed tomo-
graphy (SPECT) revealed a hyperperfusion state
over the right parietal and temporal lobes
(Fig. 2A). Brain magnetic resonance imaging showed
hyper-intense lesions on fluid-attenuated inversion
recovery-sequences (Fig. 2B) and T2-weighted
images over the right medial temporal area.
Thyroid function tests showed that serum free T4
was 2.05 ng/dL (normal, 0.79—2.01 ng/dL), T3 was
97.6 ng/dL (normal, 52—175 ng/dL), and thyroid-
stimulating hormone was below 0.2 mIU/mLver the right parietal and temporal lobes. (B) Interictal MRI
-sequences image over the right medial temporal area.
Status epilepticus in Hashimoto’s encephalopathy 715(normal, 0.25—4.0 mIU/mL). The diagnosis of Hashi-
moto’s encephalopathy was confirmed by elevated
titers of both anti-microsomal antibody and anti-
thyroglobulin antibody to 1:1600 (normal, 1:100).
Intravenous methylprednisolone 1000 mg for 3
days followed by oral prednisolone 60 mg/day was
given. Dramatic clinical improvement of conscious-
ness and cognitive function, as well as decreased
seizure frequency, was noted. Steroid was gradually
discontinued 2 months later without relapse of the
encephalopathy. Thyroid function tests returned to
normal and serum anti-thyroid antibody titer
became negative.Discussion
Because the clinical manifestations of Hashimoto’s
encephalopathy are quiet variable and nonspecific,
thediagnosis is often challenging.2 The symptoms are
usually not preceded by symptoms of dysthyroidism.
Therefore, this condition is easily under-recog-
nized.1,2 Our patient had only mild hyperthyroidism
at the time the neurologic symptoms manifested and
the clinical neurologic presentations were nonspeci-
fic. Thus, the differential diagnosis should include
viral encephalitis, Creutzfeldt-Jakob disease, cen-
tral nervous system vasculitis and other autoimmune
inflammatory encephalopathies. Whereas the nega-
tive sign of central nervous system (CNS) infection, a
normal CSF study and the absence of viral antibodies
in this patient, we excluded the possibility of infec-
tious causes. There was also no evidence of vasculitis
both in the clinical presentation and MRI study. Para-
neoplastic limbic encephalitis was not suggested due
to the young age of the patient and no subsequent
development of neoplasm during the follow-up per-
iod. More importantly, the elevated titers of anti-
thyroid antibodies eventually led to the diagnosis of
Hashimoto’s encephalopathy.
Epileptic seizures are a common clinical symptom
of Hashimoto’s encephalopathy.1—3 However, status
epilepticus rarely occurs in patientswithHashimoto’sTable 1 Status epilepticus in patients with Hashimoto’s en
Patient Age/sex Seizure type A
1 [Ref. 8] 42/F GCSE P
2 [Ref. 6] 40/M GCSE P
3 [Ref. 7] 41/M GCSE P
4 [Ref. 10] 27/F GCSE P
5 [Ref. 9] 61/F GASE —
6 [Ref. 5] 37/F EPC P
7 [present] 16/F CPSE P
M: male; F: female; GCSE: generalized convulsive status epilepticus
partial statue epilepticus; —: not available; AED: antiepileptic druencephalopathy. Our patient exhibited fluctuating
clinical presentations, including memory deficits,
bizarre behavior, psychosis, and confusion. Ictal
EEG demonstrated right lateralized high amplitude
rhythmic delta waves associated with episodic
altered mental status suggestive of complex partial
status epileptics.
Intriguingly, the SPECT revealed regional hyper-
perfusion in the right parietal and temporal lobes,
which correlated with the lateralized high ampli-
tude rhythmic delta waves on the EEG. We are
aware that most reported cases of Hashimoto’s
encephalopathy showed reversible diffuse or focal
hypoperfusion on SPECT during the interictal
stage.4,5 Vascular insufficiency caused by vasculitis
had been proposed as the underlying pathogenesis.5
In this patient, the ictal seizure activities might
contribute to the hyperperfusion change in regional
cerebral cortex that further supports the diagnosis
of complex partial status epileptics.
A Medline research conducted to identify pub-
lished papers regarding status epilepticus asso-
ciated with Hashimoto’s encephalopathy between
1967 and February 2007 showed only six patients
(Table 1).6—11 With our patient, there were five
females and two males. The age ranged from 16
to 61 years. Except for our patient (Patient 7), four
(Patients 1—4)7—9,11 had generalized convulsive sta-
tus epilepticus, one (Patient 5)10 had generalized
absence status epilepticus, and one (Patient 6)6 had
epilepsia partialis continua.
The prognosis of status epilepticus remains poor,
with prompt seizure control and treatment of the
underlying etiology as the principal management
considerations in clinical practice. In our patient
and the six reported cases of Hashimoto’s ence-
phalopathy that had status epilepticus, antiepilep-
tic drug therapy was ineffective. Among the seven
patients, five (Patients 1, 3 and 5—7) had good
response to intravenous steroid therapy. Two
patients (Patients 2 and 4)7,11 did not response
to steroid therapy and had an unfavorable out-
come. Accordingly, poor response to steroid ther-cephalopathy
ED response Steroid response Prognosis
oor Good Recovery
oor Poor Death
oor Good Recovery
oor Poor Death
Good Recovery
oor Good Recovery
oor Good Recovery
; GASE: generalized absence status epilepticus; CPSE: complex
g; EPC: epilepsia partialis continua.
716 M.-H. Tsai et al.apy, general convulsive status epilepticus, and
extended involvement of brain structures might
be associated with poor prognosis in Hashimoto’s
encephalopathy. Therefore, Hashimoto’s encepha-
lopathy might be a treatable etiology for status
epilepticus and aside from antiepileptic drugs,
intravenous steroid therapy should be started as
soon as possible to prevent the unfavorable results.
For those unresponsive to steroid therapy, plasma-
pheresis and intravenous immunoglobulin had been
suggested.12,13 But whether plasmapheresis,
immuno-suppressants, or intravenous immunoglo-
bulins are effective for steroid-resistant cases
need further study.
The pathogenesis of Hashimoto’s encephalopathy
is unclear. Proposed mechanisms include autoim-
mune CNS vasculitis, anti-neuronal antibody-
mediated reaction, and an autoimmune reaction
to antigens shared by the thyroid and CNS.14
Although anti-thyroid antibodies are essential in
the diagnosis of Hashimoto’s encephalopathy, their
levels do not correlate with the severity of neuro-
logic deficits.14
The role of anti-thyroid antibodies in epileptic
seizures in Hashimoto’s encephalopathy is unknown.
Recent studies have suggested that auto-antibodies,
such as anti-glutamic acid decarboxylase antibody
or anti-voltage gated potassium channel antibody,
may contribute to certain forms of epilepsy or
seizure-associated disorders.15 Whether the anti-
thyroid antibodies themselves harbor effects on
neurons, which lead to epileptogenesis in Hashimo-
to’s encephalopathy, needs further researches.
In conclusion, complex partial status epilepticus
can occur in Hashimoto’s encephalopathy. Although
Hashimoto’s encephalopathy is a treatable condi-
tion, the associated status epilepticus is often
refractory to antiepileptic drug therapy. Screening
of serum anti-thyroid antibodies for unexplained
encephalopathy with epileptic seizures should be
suggested. Early recognition of this disease and
prompt steroid treatment may lead to a favorable
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